We are live on ! Find out more
GTCM

Gyon Technologies Capital Management Portfolio holdings

AUM $267M
1-Year Est. Return 11.62%
This Fund
S&P 500
This Quarter Est. Return
+7.63%
1 Year Est. Return
-11.62%
3 Year Est. Return
+42.22%
5 Year Est. Return
10 Year Est. Return
AUM
$542M
AUM Growth
+$171M
Cap. Flow
+$154M
Cap. Flow %
28.41%
Top 10 Hldgs %
11.37%
Holding
677
New
315
Increased
135
Reduced
94
Closed
132

Sector Composition

Rank Sector Weight
1 Technology 20.16%
2 Financials 18.57%
3 Healthcare 17.16%
4 Industrials 12.11%
5 Consumer Discretionary 9.02%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PODD icon
201
Insulet
PODD
$11.6B
$779K 0.14%
2,928
+1,988
+211% +$577K
HUN icon
202
Huntsman Corp
HUN
$1.83B
$777K 0.14%
22,279
+6,473
+41% +$211K
TRMB icon
203
Trimble
TRMB
$13.9B
$777K 0.14%
+8,913
New +$765K
LHX icon
204
L3Harris
LHX
$53.1B
$775K 0.14%
+3,636
New +$806K
FOCS
205
DELISTED
Focus Financial Partners Inc. Class A
FOCS
$762K 0.14%
12,754
+8,212
+181% +$511K
PCVX icon
206
Vaxcyte
PCVX
$7.9B
$746K 0.14%
+31,342
New +$729K
GL icon
207
Globe Life
GL
$14.3B
$740K 0.14%
7,892
+2,145
+37% +$198K
XLC icon
208
State Street Communication Services Select Sector SPDR ETF
XLC
$22.6B
$739K 0.14%
+9,512
New +$752K
NBIS
209
Nebius Group N.V.
NBIS
$57.3B
$734K 0.14%
+12,124
New +$893K
WM icon
210
Waste Management
WM
$90B
$729K 0.13%
4,369
+1,389
+47% +$223K
DOX icon
211
Amdocs
DOX
$6.02B
$725K 0.13%
9,690
+977
+11% +$73.3K
AMK
212
DELISTED
AssetMark Financial Holdings, Inc.
AMK
$721K 0.13%
27,504
+17,647
+179% +$457K
CLDX icon
213
Celldex Therapeutics
CLDX
$3.07B
$711K 0.13%
18,388
-17,376
-49% -$757K
AQN icon
214
Algonquin Power & Utilities
AQN
$4.46B
$709K 0.13%
49,041
+3,786
+8% +$54.2K
CNA icon
215
CNA Financial
CNA
$14.3B
$709K 0.13%
16,086
-5,323
-25% -$237K
FHI icon
216
Federated Hermes
FHI
$4.85B
$708K 0.13%
18,829
-12,117
-39% -$420K
GM icon
217
General Motors
GM
$77.5B
$708K 0.13%
12,074
-49,645
-80% -$2.9M
RMD icon
218
ResMed
RMD
$32.4B
$702K 0.13%
2,695
+1,144
+74% +$297K
NWSA icon
219
News Corp Class A
NWSA
$15.5B
$700K 0.13%
+31,363
New +$717K
BCRX icon
220
BioCryst Pharmaceuticals
BCRX
$2.29B
$697K 0.13%
+50,291
New +$666K
NVO
221
Novo Nordisk
NVO
$196B
$695K 0.13%
12,402
-718
-5% -$38.9K
NWS icon
222
News Corp Class B
NWS
$17.7B
$687K 0.13%
+30,532
New +$699K
LDOS icon
223
Leidos
LDOS
$16.4B
$681K 0.13%
+7,655
New +$717K
NWL icon
224
Newell Brands
NWL
$2.61B
$678K 0.13%
31,029
+2,347
+8% +$53K
HR icon
225
Healthcare Realty
HR
$7.02B
$674K 0.12%
+20,196
New +$674K

Similar funds

Gyon Technologies Capital Management's Q4 2021 Portfolio in Review

As of Q4 2021, Gyon Technologies Capital Management held 677 positions worth $542M, up 46% from $371M the previous quarter. Its ten largest holdings account for 11% of the portfolio.

Gyon Technologies Capital Management deployed $154M of net new capital in Q4 2021, opening 315 new positions and adding to 135 existing holdings. Its largest new stake was Amazon: 48,300 shares worth $8.05M.

By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 18% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was Canadian National Railway, an estimated $4.04M trimmed.

  • Gyon Technologies Capital Management's largest Q4 2021 buy was Amazon: 48,300 shares worth $8.05M.
  • Gyon Technologies Capital Management added most to Everest Group in Q4 2021, an estimated $5.2M increase.
  • Gyon Technologies Capital Management's biggest Q4 2021 reduction was Canadian National Railway, cutting an estimated $4.04M.
  • Gyon Technologies Capital Management fully exited TJX Companies in Q4 2021, selling an estimated $4.5M.
  • Gyon Technologies Capital Management's ten largest holdings make up 11% of its $542M portfolio in Q4 2021.
  • Gyon Technologies Capital Management opened 315 new positions and closed 132 in Q4 2021.
  • Gyon Technologies Capital Management's portfolio value rose 46% quarter-over-quarter to $542M.

Based on Gyon Technologies Capital Management's 13F filing for Q4 2021, filed 11 Feb 2022.